Literature DB >> 22209306

Remission from alcohol and other drug problem use in public and private treatment samples over seven years.

Kevin L Delucchi1, Andrea H Kline Simon, Constance Weisner.   

Abstract

BACKGROUND: The treatment of alcohol and other drugs is now more commonly framed in terms of a chronic condition which requires ongoing monitoring. A model which includes continuing access to health care may optimize outcomes. Most studies of chronic care models have not included health care and have only examined short term effects.
METHODS: The sample (n = 783) included consecutive admissions in ten public and private alcohol and other drug (AOD) treatment programs followed over seven years. The outcome was remission which was defined as alcohol and drug abstinence or non-problem use.
RESULTS: In the private sample, receiving health care services predicted remission across the seven years; however this did not occur in the public sample. More patients in the public treatment sample received AOD treatment readmissions each year, while more of those in the private sector received psychiatric and general health visits. Except for drug problem severity, there were no other clinical differences between the samples. There were no differences in the proportions of patients in the two sectors who received the full spectrum of chronic care services. In the final models, 12-step participation was markedly significant for both samples.
CONCLUSIONS: Models of chronic care for substance use need to consider differences between private and public treatment and should take into account that individuals may not always have access, or avail themselves of services that may optimize long-term outcomes.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22209306      PMCID: PMC3331965          DOI: 10.1016/j.drugalcdep.2011.12.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  35 in total

1.  Social reinforcement of substance abuse aftercare group therapy attendance.

Authors:  S J Lash; G E Petersen; E A O'Connor; L P Lehmann
Journal:  J Subst Abuse Treat       Date:  2001-01

2.  Social reinforcement of substance abuse treatment aftercare participation: Impact on outcome.

Authors:  Steven J Lash; Jennifer L Burden; Brian R Monteleone; Lauren P Lehmann
Journal:  Addict Behav       Date:  2004-02       Impact factor: 3.913

3.  The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients.

Authors:  Jennifer R Mertens; Alan J Flisher; Derek D Satre; Constance M Weisner
Journal:  Drug Alcohol Depend       Date:  2008-06-20       Impact factor: 4.492

4.  Continuing care and long-term substance use outcomes in managed care: early evidence for a primary care-based model.

Authors:  Felicia W Chi; Sujaya Parthasarathy; Jennifer R Mertens; Constance M Weisner
Journal:  Psychiatr Serv       Date:  2011-10       Impact factor: 3.084

5.  Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.

Authors:  Sujaya Parthasarathy; Constance M Weisner
Journal:  Drug Alcohol Depend       Date:  2005-11-01       Impact factor: 4.492

6.  Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.

Authors:  Peter D Friedmann; Zhiwei Zhang; James Hendrickson; Michael D Stein; Dean R Gerstein
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

7.  Helping, spirituality and Alcoholics Anonymous in recovery.

Authors:  Sarah E Zemore; Lee Ann Kaskutas
Journal:  J Stud Alcohol       Date:  2004-05

Review 8.  Alcoholics anonymous effectiveness: faith meets science.

Authors:  Lee Ann Kaskutas
Journal:  J Addict Dis       Date:  2009

9.  Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls.

Authors:  Jennifer R Mertens; Yun W Lu; Sujaya Parthasarathy; Charles Moore; Constance M Weisner
Journal:  Arch Intern Med       Date:  2003-11-10

10.  The case for chronic disease management for addiction.

Authors:  Richard Saitz; Mary Jo Larson; Colleen Labelle; Jessica Richardson; Jeffrey H Samet
Journal:  J Addict Med       Date:  2008-06       Impact factor: 3.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.